Comparing the Efficacy and Safety of IL-17 Inhibitorsfor Treatment of Moderate-To-Severe Psoriasis: A Randomized Double Blind Pilot Study With a Review of Literature

Postepy Dermatologii I Alergologii - Poland
doi 10.5114/ada.2019.91496
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

SKIN The Journal of Cutaneous Medicine
2019English

AB0954 a Randomised, Double-Blind Trial Comparing the Efficacy, Safety and Immunogenicity of Msb11022, a Proposed Biosimilar of Adalimumab, Versus Adalimumab Originator in Patients With Moderate-To-Severe Plaque Psoriasis

2018English

Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-To-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

The Effect of Secukinumab on Moderate-To-Severe Scalp Psoriasis: Results of a 24-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3b Study

Journal of the American Academy of Dermatology
Dermatology
2017English

To: A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease

Neurology
Neurology
2001English

Ixekizumab Efficacy and Safety in Moderate-To-Severe Genital Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Intramuscular Versus Oral Dexamethasone for the Treatment of Moderate-To-Severe Croup: A Randomized, Double-Blind Trial

Academic Emergency Medicine
MedicineEmergency Medicine
2003English

Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study

British Journal of Dermatology
DermatologyMedicine
2019English

Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis

Biopharmaceutics and Drug Disposition
MedicinePharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy